Good governance for medicines: moving towards a national framework

摘要

Access to and affordability of essential medicines are integral to universal health coverage, particularly as a large part of private and public health expenditure is on medicines. The value of the global pharmaceutical market is therefore immense and the pharmaceutical sector as a result is very open to abuse, corruption and unethical practices. Indeed corruption in procurement/distribution of pharmaceutical and medical supplies and lack of transparency and checks and balances make medicines one of the common causes of inefficiency in health systems.